Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil ... and helped build a case against the pharmaceutical industry before judges ...

There are other games, seemingly by other creators, on both Google Play and the iOS App Store that appear to be influenced by Poppy Playtime, but which don’t appear to use the copyrighted Poppy ...

Japanese pharmaceutical company Takeda inaugurated its first Innovation Capability Centre (ICC) in Bengaluru, marking its debut in Asia. The ICC aims to employ 750 professionals, including software ...

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year. After an explosive opening marked by a suite of ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

The growing investment in India's CDMO sector indicates confidence in India’s pharmaceutical sector and its potential - A detailed analysis. With the U.S. increasingly adopting an anti-China ...

Monday, three Big Pharma leaders took center stage and addressed concerns about future patent expirations head-on. In separate presentations, the CEOs of Bristol Myers Squibb, Pfizer and Merck ...

Executives at Amgen made the case for MariTide’s differentiation, while Merck’s CEO contended that Keytruda’s ... aims to compete in a market now dominated by big pharma. As such, analysts have ...

Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

Poppy Playtime Chapter 1 took the internet by storm back in 2021, and it’s easy to see why. Following the massive success of Five Nights At Freddy’s and Bendy and the Ink Machine, it capitalizes on ...

Metro Richmond Zoo launched "Poppy Cam" on Jan. 13 — allowing fans from around the world to watch the baby pygmy hippo splash around in her pool Luke Chinman is an editorial intern at PEOPLE.

Phio Pharmaceuticals shares more than tripled after the company said it saw positive results from its Phase 1b trial for its cancer treatment PH-762. Shares were recently up more than 270% to $6. ...